CCQM-K11.2 Determination of Glucose in Human Serum and CCQM-K12.2 Determination of Creatinine in Human Serum
Date
2018-01-01Author
Wise, Stephen A.Phinney, Karen W.
Duewer, David L.
Sniegoski, Lorna T.
Welch, Michael J.
Pritchett, Jeanita
Pabello, Guiomar
Avila Calderon, Marco A.
Balderas, Miryan
Liu Qinde, Liu Qinde
Kooi, Lee Tong
Rego, Eliane
Garrido, Bruno
Allegri, Gabriella
de La Cruz, Marcia
Barrabin, Juliana
Monteiro, Tania
Lee, Hwashim
Kim, Byungjoo
Delatour, Vincent
Peignaux, Maryline
Kawaguchi, Migaku
Bei, Xu
Can, Quan
Nammoonnoy, Jintana
Schild, Katrin
Ohlendorf, Ruediger
Henrion, Andre
Goren, Ahmet Ceyhan
Yilmaz, Hasibe
Bilsel, Mine
Konopelko, L.
Krylov, A.
Lopushanskaya, E.
Advisor
Type
Metadata
Show full item recordAbstract
Glucose and creatinine are two of the most frequently measured substances in human blood/serum for assessing the health status of individuals. Because of their clinical significance, CCQM-K11 Glucose in Human Serum and CCQM-K12 Creatinine in Human Serum were the fourth and fifth Key Comparisons (KCs) performed by the Organic Analysis Working Group (OAWG). These KCs were conducted in parallel and were completed in 2001. The initial Subsequent KCs for glucose, CCQM-K11.1, and creatinine, CCQM-K12.1, were completed in 2005. Measurements for the next KCs for these two measurands, CCQM-K11.2 and CCQM-K12.2, were completed in 2013. While designed as Subsequent KCs, systematic discordances between the participants- and the anchor institution-s results in both comparisons lead the OAWG to request reference results from two experienced laboratories that had participated in the 2001 comparisons. Based on the totality of the available information, the OAWG converted both CCQM-K11.2 and CCQM-K12.2 to - Track C- KCs where the Key Comparison Reference Value is estimated by consensus.